Zobrazeno 1 - 10
of 177
pro vyhledávání: '"Chieh-Kai Chan"'
Autor:
Ying-Ying Chen, Shun-Chen Huang, Chien-Ting Pan, Kang-Yung Peng, Liang-Yu Lin, Chieh-Kai Chan, Chia-Tung Shun
Publikováno v:
Journal of the Formosan Medical Association, Vol 123, Iss , Pp S135-S140 (2024)
Unilateral primary aldosteronism is thought to be a surgically curable disease, and unilateral adrenalectomy is the mainstay treatment. The Primary Aldosteronism Surgical Outcome (PASO) consensus was developed to assess clinical and biochemical outco
Externí odkaz:
https://doaj.org/article/4aacb86063b84559a61917644c2bf2c2
Autor:
Chi-Shin Tseng, Chieh-Kai Chan, Hsiang-Ying Lee, Chien-Ting Pan, Kang-Yung Peng, Shuo-Meng Wang, Kuo-How Huang, Yao-Chou Tsai, Vin-Cent Wu, Jeff S. Chueh
Publikováno v:
Journal of the Formosan Medical Association, Vol 123, Iss , Pp S125-S134 (2024)
Primary aldosteronism (PA) is the most common cause of secondary hypertension and one of the few medical diseases that can be cured by surgery. Excessive aldosterone secretion is highly associated with cardiovascular complications. Many studies have
Externí odkaz:
https://doaj.org/article/d2dfe1d945c4446083af2362b46a812c
Autor:
Li-Hsin Pan, Ying-Ying Chen, Chien-Ting Pan, Chih-Yao Hsu, Chi-Shin Tseng, I-Weng Yen, Chieh-Kai Chan, Liang-Yu Lin
Publikováno v:
Journal of the Formosan Medical Association, Vol 123, Iss , Pp S141-S152 (2024)
Primary aldosteronism (PA) is the most common form of endocrine hypertension, characterized by excess aldosterone production that leads to an increased risk of cardiovascular events and target organ damage. Both adrenalectomy and medical treatment ha
Externí odkaz:
https://doaj.org/article/d7d9748e1af5430e8db59461195fb252
Autor:
Ting-Wei Kao, Che-Wei Liao, Cheng-Hsuan Tsai, Yi-Yao Chang, Chien-Ting Pan, Chin-Chen Chang, Bo-Ching Lee, Wei-Chieh Huang, Kuo-How Huang, Ching-Chu Lu, Tai-Shuan Lai, Chieh-Kai Chan, Jeff S. Chueh, Vin-Cent Wu, Chi-Sheng Hung, Zheng-Wei Chen, Yen-Hung Lin
Publikováno v:
Therapeutic Advances in Chronic Disease, Vol 14 (2023)
Background: Primary aldosteronism (PA) has been associated with atherosclerosis beyond the extent of essential hypertension, but the impact of albuminuria remains unknown. Objective: To investigate the effect of concomitant albuminuria on arterial st
Externí odkaz:
https://doaj.org/article/3134d6bc5c564d709c334aed2fd1b4c7
Autor:
Kun-Han Yang, Ching-Yu Yen, Sheng-Chieh Wang, Fang-Rong Chang, Meng-Yang Chang, Chieh-Kai Chan, Jiiang-Huei Jeng, Jen-Yang Tang, Hsueh-Wei Chang
Publikováno v:
Biomedicines, Vol 12, Iss 2, p 458 (2024)
This in vitro study examines the anti-oral cancer effects and mechanisms of a combined X-ray/SK2 treatment, i.e., X-ray and 6-n-butoxy-10-nitro-12,13-dioxa-11-azatricyclo[7.3.1.02,7]trideca-2,4,6,10-tetraene (SK2). ATP cell viability and flow cytomet
Externí odkaz:
https://doaj.org/article/5f4dca34e1d746fc80673fda0c402624
Autor:
Vin‐Cent Wu, Chieh‐Kai Chan, Jeff S. Chueh, Yung‐Ming Chen, Yen‐Hung Lin, Chin‐Chen Chang, Po‐Chih Lin, Shiu‐Dong Chung
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 12, Iss 4 (2023)
Background Targeted treatment with mineralocorticoid receptor antagonists (MRAs) or adrenalectomy in patients with primary aldosteronism (PA) causes a decline in estimated glomerular filtration rate; however, the associated simultaneous changes in bi
Externí odkaz:
https://doaj.org/article/1fa030e9141347058d72dd79525579b0
Autor:
Chieh-Kai Chan, Yi-Yao Chang, Yi-Chun Tsai, Zheng-Wei Chen, Chun-Yi Wu, Wei-Chieh Huang, I-Weng Yen, Kuo-Hsin Wu, Vin-Cent Wu, Yen-Hung Lin, Jui-Hsiang Lin, Wei-Jie Wang, Che-Hsiung Wu, Ya-Hui Hu, Leay Kiaw Er, Chia-Hui Chang, Yao-Chou Tsai, Chih-Chin Yu, Lian-Yu Lin, Fu-Chang Hu, Chin-Chen Chang, Kao-Lang Liu, Shuo-Meng Wang, Kuo-How Huang, Shih-Chieh Jeff Chueh, Shih-Cheng Liao, Ching-Chu Lu, Ruoh-Fang Yen, Kwan-Dun Wu
Publikováno v:
Journal of the Formosan Medical Association, Vol 120, Iss 10, Pp 1811-1820 (2021)
The aim of this study was to update the information on internationally acceptable standards and clinical practice recommendations for the management of patients with primary aldosteronism (PA). The Taiwan Society of Aldosteronism (TSA) Task Force ack
Externí odkaz:
https://doaj.org/article/2cf0a55dd27b472eb3a92160a9cb149e
Autor:
Huang-Ming Chang, Kang-Yung Peng, Chieh-Kai Chan, Chiao-Yin Sun, Ying-Ying Chen, Han-Mei Chang, Chun-Lin Huang, Pei-Chun Liu, Peng-Ying Chen, Kuo-Chuan Wang, Wei-Jie Wang, Chen-Chi Wu, Yu-Feng Lin, Tai-Shuan Lai, Tao-Min Huang, Guang-Huar Young, Shuei-Liong Lin, Marlies Ostermann, Tzong-Shinn Chu, Jeff S. Chueh, Vin-Cent Wu
Publikováno v:
Cell Death and Disease, Vol 12, Iss 5, Pp 1-19 (2021)
Abstract The levels of fibroblast growth factor 23 (FGF23) rapidly increases after acute kidney injury (AKI). However, the role of FGF23 in AKI is still unclear. Here, we observe that pretreatment with FGF23 protein into ischemia-reperfusion induced
Externí odkaz:
https://doaj.org/article/d2eca9498dc2425f972bfbbf882186af
Publikováno v:
ACS Omega, Vol 6, Iss 11, Pp 7296-7311 (2021)
Externí odkaz:
https://doaj.org/article/7a05be13dc64437e9c0bf9220a878e07
Autor:
Yi-Ting Chen, Chieh-Kai Chan, Wen-Yi Li, Tao-Min Huang, Tai-Shuan Lai, Vin-Cent Wu, Tzong-Shinn Chu
Publikováno v:
Journal of the Formosan Medical Association, Vol 120, Iss 1, Pp 641-650 (2021)
Background/Purpose: Chronic kidney disease (CKD) is a risk factor for contrast associated acute kidney injury (CA-AKI). The risk of renin-angiotensin-aldosterone system inhibitor (RASi) use in patients with CKD before the administration of contrast i
Externí odkaz:
https://doaj.org/article/3854db1e9d254a2abf5051e28343b497